Apollo Hospitals Enterprise is currently trading at Rs. 1140.35, up by 19.70 points or 1.76% from its previous closing of Rs. 1120.65 on the BSE.
The scrip opened at Rs. 1123.00 and has touched a high and low of Rs. 1149.90 and Rs. 1123.00 respectively. So far 5264 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1219.55 on 27-Aug-2014 and a 52 week low of Rs. 817.00 on 19-Dec-2013.
Last one week high and low of the scrip stood at Rs. 1149.90 and Rs. 1033.45 respectively. The current market cap of the company is Rs. 15889.48 crore.
The promoters holding in the company stood at 34.35% while Institutions and Non-Institutions held 45.57% and 19.34% respectively.
Apollo Hospitals and Sanofi have decided to collaborate on the expansion of Apollo Sugar Clinics, which provide integrated diabetes care programs in India. Through this collaboration, Apollo and Sanofi plan to leverage their respective expertise in diabetes to provide patients with access to comprehensive educational resources, treatment and care programs that can help patients better manage their diabetes. The first wave of this collaboration will focus on the establishment of 50 Apollo Sugar Clinics.
Apollo Hospitals is the leading private sector healthcare provider in Asia and owns and manages a network of speciality hospitals and clinics, a chain of Pharmacy retail outlets across the country, and provides Consultancy Services for commissioning and managing the Speciality Hospitals.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7699.05 |
| Max Healthcare Inst | 1006.90 |
| Narayana Hrudayalay | 1825.55 |
| Aster DM Healthcare | 688.30 |
| Global Health | 1089.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: